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BMP Signaling Induces Cell-Type-Specific Changes in
Gene Expression Programs of Human Keratinocytes
and Fibroblasts
Michael Y. Fessing1, Ruzanna Atoyan2, Ben Shander2, Andrei N. Mardaryev1, Vladimir V. Botchkarev Jr3,
Krzysztof Poterlowicz4, Yonghong Peng4, Tatiana Efimova5 and Vladimir A. Botchkarev1,2
BMP signaling has a crucial role in skin development and homeostasis, whereas molecular mechanisms
underlying its involvement in regulating gene expression programs in keratinocytes and fibroblasts remain
largely unknown. We show here that several BMP ligands, all BMP receptors, and BMP-associated Smad1/5/8 are
expressed in human primary epidermal keratinocytes and dermal fibroblasts. Treatment of both cell types by
BMP-4 resulted in the activation of the BMP–Smad, but not BMP–MAPK pathways. Global microarray analysis
revealed that BMP-4 treatment induces distinct and cell type-specific changes in gene expression programs in
keratinocytes and fibroblasts, which are far more complex than the effects of BMPs on cell proliferation/
differentiation described earlier. Furthermore, our data suggest that the potential modulation of cell adhesion,
extracellular matrix remodeling, motility, metabolism, signaling, and transcription by BMP-4 in keratinocytes and
fibroblasts is likely to be achieved by the distinct and cell-type-specific sets of molecules. Thus, these data
provide an important basis for delineating mechanisms that underlie the distinct effects of the BMP pathway on
different cell populations in the skin, and will be helpful in further establishing molecular signaling networks
regulating skin homeostasis in health and disease.
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INTRODUCTION
Bone morphogenetic protein (BMP) signaling has important
roles in regulating multiple functions in developing and
postnatal skin, including the control of cellular proliferation
and differentiation, epithelial–mesenchymal interactions,
melanogenic activity and tissue remodeling (reviewed in
(Botchkarev, 2003)). BMPs are also involved in controlling
the variety of pathobiological processes in the skin, including
wound healing, psoriasis, and carcinogenesis (Blessing et al.,
1995, 1996; Kaiser et al., 1998) Data obtained during the last
decade revealed that BMP signaling is capable of modulating
the activity of major cellular components of the skin
including epidermal and hair follicle keratinocytes, dermal
fibroblasts, melanocytes, and epithelial stem cells (D’Souza
et al., 2001a; Park and Morasso, 2002; Kobielak et al., 2003,
2007; Sharov et al., 2003, 2005; Andl et al., 2004; Plikus
et al., 2004; Zhang et al., 2006). However, despite its broad
involvement in the control of skin homeostasis and remodel-
ing, the mechanisms of regulation and transcriptional targets
for BMP signaling in distinct skin cell populations remain to
be elucidated.
BMPs belong to the transforming growth factor-b (TGF-b)
superfamily and bind to the transmembrane receptor complex
formed by the type I (ActR-I/Alk-2, BMPR-IA/Alk-3, BMPR-IB/
Alk-6) and type II (BMPR-II, ActR-IIA, ActR-IIB) receptors
(Miyazono et al., 2005; Kitisin et al., 2007). Ligand binding to
the BMP receptor complex results in phosphorylation of the
intracellular domain of the type I receptor by the type II
receptor kinase domain and leads to transmission of a signal
through the BMP–Smad and/or BMP–MAPK pathways (Miya-
zono et al., 2005; Kitisin et al., 2007). BMP-specific Smad
proteins (Smad1/5/8 or receptor-activated Smads, R-Smads)
after phosphorylation form a heteromeric complex with Smad4
(or common partner Smad, Co-Smad) and translocate to the
nucleus to regulate the transcription of the BMP-responsive
genes. The BMP–MAPK pathway could also use several key
MAP kinases (p38, JNK, and/or Erk1/2) (Nohe et al., 2004),
whereas the mechanisms and biological effects of this pathway
in cells are much less understood.
Epidermal keratinocytes and dermal fibroblasts are major
cellular components of the skin, and their interactions
are critical for the proper control of skin development
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and postnatal homeostasis (Fuchs, 2007). BMP signaling
serves as a powerful regulator of epithelial–mesenchymal
interactions in developing skin and is also capable of
modulating the functional activity of keratinocytes and
fibroblasts postnatally (Botchkarev, 2003; Botchkarev and
Kishimoto, 2003). Moreover, the effects of BMPs on cellular
targets strongly depend on the levels and activity of
extracellular BMP antagonists, including Noggin that
inhibits ligand binding to the BMP receptor complex, and
modulate a magnitude of BMP signaling (Balemans and Van
Hul, 2002).
Data obtained from cultured mouse keratinocytes show
that cell infection with BMP-6-expressing adenovirus (Drozd-
off et al., 1994) or its treatment with recombinant BMP-2 or
BMP-6 proteins under distinct culture conditions led to the
induction of keratinocyte differentiation (McDonnell et al.,
2001; D’Souza et al., 2001b; Park and Morasso, 2002) Thus,
in differentiating mouse epidermal keratinocytes, BMP6-
stimulated keratin 1 and involucrin expression through the
BMP–Smad pathway (McDonnell et al., 2001; D’Souza et al.,
2001b), and BMP2 activated the expression of the Dlx-3
transcription factor (Park and Morasso, 2002). However,
stimulatory effects of BMP-2/6 on the differentiation process
in human epidermal keratinocytes are seen only in the
absence of EGF in culture medium as EGF purportedly exerts
an inhibitory effect on the BMP pathway (Gosselet et al.,
2007).
Data obtained from BMP-6 transgenic mice (promoter:
keratin 10) show that high levels of BMP-6 in the epidermis
inhibit epidermal proliferation, whereas a moderate level of
the transgene expression stimulated epidermal proliferation,
indicating that the biological effect of BMP signaling depends
on the intensity of the signal (Blessing et al., 1996). This is
consistent with the data obtained from Noggin transgenic
mice (promoter: keratin 5) that show increased epidermal
proliferation and decreased expression of keratinocyte
differentiation markers (Sharov et al., 2003).
In contrast to keratinocytes, the effects of BMP signaling
on dermal fibroblasts are only poorly understood. BMP-2
treatment of human dermal fibroblasts in 3D culture leads to
their chondrogenic differentiation (Zhou et al., 2004). Noggin
overexpression in the epidermal keratinocytes is accompa-
nied by a thickening of the dermis, suggesting the effects of
the BMPs on fibroblast collagen-producing activity (Sharov
et al., 2003). Constitutive deletion of Noggin in mice is
accompanied by an increase of p75 kDa neurotrophin
receptor expression in the population of dermal fibroblasts
that form the follicular papilla (Botchkarev et al., 1999), in
which BMP signaling is important for the maintenance of
hair-inductive properties (Rendl et al., 2008).
Global microarray data reveal that BMP signaling is
involved in regulating the expression of over 500 genes in
distinct cell types outside of the skin (Locklin et al., 2001;
Vaes et al., 2002; Balint et al., 2003; Korchynskyi et al.,
2003; Miyoshi et al., 2008). However, the complex effects of
BMP signaling on epidermal keratinocytes and dermal
fibroblasts remain unknown. By using global microarray
analysis, we show here that BMP signaling causes distinct
and cell-type-specific changes in gene expression programs
in human primary epidermal keratinocytes and dermal
fibroblasts, thus suggesting its involvement in the complex
regulation of cell adhesion, extracellular matrix remodeling,
cellular motility, metabolism, signaling, and transcription in
both cell types.
RESULTS AND DISCUSSION
Components of the BMP-signaling pathway are expressed in
human keratinocytes and fibroblasts
First, we analyzed the expression of the transcripts for
distinct components of the BMP signaling pathway in primary
human epidermal keratinocytes and dermal fibroblasts.
Under normal culture conditions, both cell types expressed
all subtypes of the BMP and activin receptors (BMPR-IA/
Alk-3, BMPR-IB/Alk-6, BMPR-II, ActR-I/Alk-2, ActR-IIA, and
ActR-IIB), as well as at least several BMP receptor ligands
including BMP-2/4/6 (Figure 1). These results were consistent
with data published earlier (Hwang et al., 2001) and
suggested that human epidermal keratinocytes and
dermal fibroblasts serve as sources and targets of BMP
signaling.
BMP-4 treatment leads to activation of the BMP–Smad pathway
in human epidermal keratinocytes and dermal fibroblasts
Ligand binding to the BMP receptor complex results in
activation of signaling through the SMAD and/or MAP kinase
pathways depending on the cell type and conditions
(Miyazono et al., 2005). Binding of the BMP ligands to
preformed type I and type II receptor heteromeric complexes
leads to activation of SMAD signaling, whereas ligand
binding to homomeric type I or type II receptor followed by
the formation of a heteromeric receptor complex is likely to
result in the activation of the BMP–MAPK pathway (Nohe
et al., 2002, 2004). Treatment of keratinocytes and fibroblasts
with BMP-4 for a different duration of time resulted in an
increase in Smad1/5/8 phosphorylation in both cell types
(Figure 2).
As shown in Figure 2, cultured keratinocytes and
fibroblasts showed differential profiles of constitutive activity
of the three MAP kinases (p38, Erk1/2, and JNK) under basal
unstimulated conditions. Despite differences in the endogen-
ous levels of phospho-MAP kinases between keratinocytes
and fibroblasts, BMP-4 treatment did not cause any sig-
nificant alterations in their constitutive phosphorylation
levels in either cell type (Figure 2), as well as in the levels
of the corresponding total proteins (data not shown). MAP
kinase pathways are activated by a number of growth factors
including the components of EGF and TGF-b signaling (Eckert
et al., 2002). Interactions between the BMP and MAPK
pathways are complex, and the active MAPK pathway is
capable of inhibiting BMP–Smad signaling through the
phosphorylation of the linker region of R-SMADs, prevention
of their interaction with SMAD4, and translocation into the
nucleus (Kretzschmar et al., 1997). Our data showed that
despite constitutive MAPK signaling, BMP-4 treatment of
epidermal keratinocytes and dermal fibroblasts activated the
BMP–Smad pathway in both cell types (Figure 2).
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BMP-4 treatment differentially affects gene expression
programs in human epidermal keratinocytes and dermal
fibroblasts
To define changes in gene expression programs triggered by
the BMP-4 treatment in human epidermal keratinocytes and
dermal fibroblasts, RNA samples were processed for global
microarray analysis using the Affymetrix Human Genome
platform, as described previously (Mammucari et al., 2005).
RNA was isolated from cells treated with recombinant BMP-4
or vehicle control for 8 hours to reveal genes that form the
early and intermediate responses to BMP-4 stimulation. The
microarray data have been deposited in NCBI’s Gene
Expression Omnibus (Edgar et al., 2002) and are accessible
through GEO Series accession number GSE16111. Gene
expression was considered significantly altered if changes in
the normalized hybridization signal were 1.8 fold or greater
than those in the corresponding controls. Alterations in the
expression levels of selected genes were confirmed by
quantitative RT-PCR, and the RT-PCR results were generally
consistent with the data of microarray analysis (Figure 3a–c).
Microarray analysis showed that, after BMP-4 treatment,
the expression of only 17 genes showed similar changes in
the expression levels of both keratinocytes and fibroblasts
(Supplementary Table 1). This group of genes included well-
known BMP targets (Miyazono et al., 2005), such as
inhibitors of DNA-binding (ID1/2/3/4), components of the
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Figure 1. Ligand and receptors of the BMP signaling pathway are expressed
in human primary epidermal keratinocytes and dermal fibroblasts. RNA was
isolated from the human keratinocytes and fibroblasts and analyzed by semi-
quantitative RT-PCR using primers specific for the indicated genes.
Representative examples of three to four experiments are shown. RNA
dilution without reverse transcription was used as a negative control.
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Figure 2. BMP signaling results in activation of the BMP–SMAD, but not
BMP–MAPK, pathways in human keratinocytes and fibroblasts. Epidermal
keratinocytes (a) and dermal fibroblasts (b) were treated with 50 ngml–1
recombinant BMP-4 or vehicle control, and the cell lysates were prepared at
different time points and analyzed by immunoblotting using antibodies
against phospho-Smad1/5/8, phospho-p38 MAPK, phospho ERK1/2, and
phospho-JNK. Representative examples of three to four experiments are
shown.
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BMP pathway (SMAD6/7) and DLX2 transcription factor
(Figure 3a and Supplementary Table 1). In addition, several
other genes including tropomyosin 1-a were upregulated in
both keratinocytes and fibroblasts after BMP-4 treatment
(Supplementary Table 1).
However, expression of the vast majority of genes showed
cell-type-specific dynamics after BMP-4 treatment and was
changed only in one cell type whereas remaining unaltered
in the other cell type (keratinocytes, 166 genes, fibroblasts,
229 genes, respectively; Supplementary Tables 2 and 3).
Large numbers of these genes were expressed at comparable
levels in both cell types, whereas a certain portion of genes
(about 39% in keratinocytes and about 22% in fibroblasts)
whose expression was altered by BMP-4 in one cell type
showed only very low expression levels in the other cell type
(Supplementary Tables 2 and 3). This observation suggested
that the differential effects of BMP signaling on gene
expression in distinct cell types may depend on a number
of mechanisms, including those controlling the basal expres-
sion levels of the BMP target genes.
Genes whose expression was changed after BMP-4
treatment in a cell-type-specific manner belonged to distinct
functional classes including those encoding cell adhesion/
extracellular matrix proteins, metabolic and proteolytic
enzymes, components of the cytoskeleton, and molecules
involved in cellular signaling and transcription (Figure 3d–f,
Supplementary Tables 2, 3). These results showed the
complex effects of BMP-4 on gene expression programs in
both keratinocytes and fibroblasts, which are consistent with
earlier observations showing similar effects of BMPs on other
cell types (Locklin et al., 2001; Vaes et al., 2002; Balint et al.,
2003; Korchynskyi et al., 2003; Miyoshi et al., 2008).
However, our data suggested that a modulation of gene
expression programs by BMP-4 in keratinocytes and fibro-
blasts is achieved by recruitment of distinct sets of molecules,
which appears to be specific for each cell type.
Interestingly, BMP-4 treatment did not cause changes of
proliferative activity in either keratinocytes or fibroblasts,
nor did it alter the expression of cyclin-dependent kinase
inhibitors, such as p21Cip1 and p27Kip1, described previously
as TGF-b/BMP targets that promote cell differentiation
(Pardali et al., 2005; Sharov et al., 2006) (data not shown).
Under our culture conditions, BMP-4 treatment of primary
keratinocytes did not affect the expression of differentiation
markers, such as involucrin, loricrin, or suprabasal keratins
(data not shown). We assume that the presence of other
growth modulators, that is, EGF in culture media, may affect
the BMP-4 capacity to significantly influence proliferation/
differentiation in our models.
Indeed, this hypothesis is consistent with the data
published earlier and shows a lack of the effects of BMP-2/6
on the differentiation process of primary epidermal
keratinocytes in the presence of EGF in the culture medium
(Gosselet et al., 2007). It has been proposed that EGF
prevents BMP-mediated keratinocyte differentiation by in-
hibiting BMP signaling (Gosselet et al., 2007). It is noted that
our data showed that EGF presence in the culture medium
did not preclude BMP signaling through SMAD1/5/8 phos-
phorylation in either cell type. Yet, our results do not rule out
the possibility that the EGF-mediated constitutive activity of
MAP kinases may exert a negative impact on BMP/SMAD
signaling as reported recently (Gosselet et al., 2007).
Interestingly, BMP-4 treatment of primary keratinocytes
resulted in a marked downregulation of expression of
thrombospondin 2 (Supplementary Table 2, Figure 3b),
which serves as a potent inhibitor of angiogenesis
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Figure 3. BMP signaling causes distinct changes in gene expression programs in human keratinocytes and fibroblasts. Epidermal keratinocytes and dermal
fibroblasts were treated with 50 ngml–1 of recombinant BMP-4 or vehicle control for 8 hours; the RNA was isolated from three to four experiments, pooled, and
the gene expression changes were analyzed using microarray technology with validation of the data for selected genes using quantitative RT-PCR. (a) qRT-PCR
data for selected genes similarly regulated by BMP signaling both in keratinocytes and fibroblasts. (b) qRT-PCR data for selected genes affected by BMP signaling
only in keratinocytes but not in fibroblasts. (c) qRT-PCR data for selected genes affected by BMP signaling only in fibroblasts but not in keratinocytes.
(d–f) Functional distribution of the genes similarly regulated by BMP-4 signaling in keratinocytes and fibroblasts (d), affected by BMP-4 signaling only in
keratinocytes but not in fibroblasts (e), and affected by BMP-4 signaling only in fibroblasts but not in keratinocytes (f).
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(Lawler and Detmar, 2004). These data are consistent with
reports that show the stimulatory effects of BMPs on
angiogenesis in different models (Liu et al., 2007; Araya
et al., 2008; Heinke et al., 2008). Our data, in addition to
previously proposed mechanisms, suggest that BMP signaling
may stimulate angiogenesis, at least in part, through the
inhibition of the thrombospondin 2 expression.
The data presented here are also consistent with earlier
observations showing the involvement of BMP signaling in
the regulation of extracellular matrix remodeling and activity
of matrix metalloproteinases (Rothhammer et al., 2008).
However, we show that BMP-4 treatment of keratinocytes
and fibroblasts results in modulation of the expression of cell
type-specific sets of proteolytic enzymes and their inhibitors.
In keratinocytes, BMP-4 treatment results in the increase of
expression of two members of the MMP family (MMP3 and
MMP10), whereas in fibroblasts BMP-4 stimulates the
expression of the ADAMS family of proteinases (ADAMTS5
and ADAM12; Supplementary Tables 2 and 3, Figure 3b and c).
As the MMP and ADAMS subfamilies of metalloprotei-
nases have different extracellular targets for cleavage and/or
degradation (Malemud, 2006), distinct effects of BMP-4 on
their expression in keratinocytes and fibroblasts may reflect a
distinct requirement of these molecules for modulating a
tissue-specific microenvironment of these cells.
BMP-4 treatment also induced cell-type-specific changes
in expression of the distinct components of the Wnt, NF-kB,
IGF, FGF, Notch pathways suggesting the involvement of the
BMP pathway in modulating regulatory signaling networks in
keratinocytes and fibroblasts (Supplementary Tables 2 and 3).
Interestingly, BMP-4 induced significant cell-type-specific
change in BMP-6 expression in keratinocytes (Figure 3b;
Supplementary Table 2). These data suggested the existence
of a positive regulatory loop in BMP signaling in this cell type
in addition to negative feedback loops characterized earlier
(Kretzschmar et al., 1997; Miyazono et al., 2005; Gazzerro
and Canalis, 2006).
Our data showing distinct responses to BMP-4 stimulation
in keratinocytes and fibroblasts raise a question about
mechanisms that determine cell type-dependent specificity
in the effects of BMP signaling on the expression of its target
genes. Most likely, such cell type-dependent contexts are
determined by many factors, a combination of which results
in the distinct effects of the BMP pathway on gene expression
programs in keratinocytes versus fibroblasts. In particular, it
has been shown that distinct BMP target genes may require
different thresholds of the signal to trigger changes in their
expression levels (Dosch et al., 1997), and such signaling
thresholds could be different in distinct cell types.
Furthermore, the presence or absence of distinct coregu-
lators of gene expression and/or distinct patterns of the
promoter (s)/enhancer (s) of chromatin methylation/acetyla-
tion may also underlie cell-type-specific differences in the
effects of BMP signaling on keratinocytes and fibroblasts
(Misteli, 2007). Another possibility explaining the differential
regulation of gene expression by BMPs in distinct cell types
could be the differences in their high-order chromatin
structure and localization of the BMP target genes relative
to distinct intra-nuclear functional compartments, such as eu-
and heterochromatin, which may affect the accessibility of
the targets for Smad transcription complexes (Lanctot et al.,
2007).
In summary, we report here what we believe to be the first
comprehensive comparative microarray analysis of global
changes in gene expression programs induced by BMP-4 in
human epidermal keratinocytes and dermal fibroblasts. We
show that the BMP-Smad pathway is active in both cell types
and that its activation is accompanied by distinct changes
in the transcriptomes of keratinocytes and fibroblasts, which
are far more complex than the effects of BMPs on cell
proliferation/differentiation described previously. Further-
more, our data suggest that the potential modulation of cell
adhesion, extracellular matrix remodeling, cellular motility,
metabolism, signaling, and transcription by BMP-4 in
keratinocytes and fibroblasts is likely to be achieved by
distinct sets of molecules specific for each cell type. Finally,
these data provide an important platform for further
delineating mechanisms that underlie the distinct effects of
the BMP pathway on different cell populations in the skin
and will be helpful in further establishing molecular
signaling networks regulating skin homeostasis in health
and disease.
MATERIALS AND METHODS
Cell culture experiments
Normal human epidermal keratinocytes and dermal fibroblasts were
isolated from neonatal foreskin, as described previously (Gilchrest,
1979; Schindler et al., 2007). Foreskin tissue was obtained using a
protocol approved by the University of Boston Institutional Review
Board in accordance with HIPAA and the Declaration of Helsinki
Principles. Patient consent was not required. Keratinocytes were
plated in serum-free keratinocyte medium (defined keratinocytes-
SFM, Invitrogen, San Diego, CA) containing 0.15mM calcium
chloride and antibiotic–antimicotic mixture. Two days before the
experiment, the cells were put in the medium containing 0.05mM
calcium chloride. Neonatal fibroblasts were grown in Dulbecco’s
Modification of Eagle’s Medium (DMEM, Invitrogen), containing
10% fetal bovine serum (HyClone, Logan, UT) and antibiotic–anti-
micotic mixture (100 ; Invitrogen). Keratinocytes and fibroblasts
were used in all the experiments at the third passage at 40–60%
confluence. The cells were treated with 50ngml–1 recombinant
human BMP-4 (R&D Systems, Minneapolis, MN) or diluent
control. Fresh medium was added to the cells 4 hours before
BMP-4 addition.
Western blot analysis
Western blot analysis of total cellular proteins was performed, as
described earlier (Sharov et al., 2003, 2005). All experiments were
performed using at least three to four replicates. Antibody reaction was
performed with rabbit monoclonal anti-phospho-p38 MAPK (Cell
Signaling, Danvers, MA), rabbit monoclonal anti-phospho ERK1/2
(Cell Signaling), rabbit polyclonal anti-p38 MAPK (Sigma, St Louis,
MO), rabbit polyclonal anti-ERK1/2 (Sigma), rabbit polyclonal
anti-phospho JNK (Sigma), rabbit polyclonal anti-JNK (Sigma), mouse
monoclonal anti-b-actin antibodies (Sigma), or rabbit polyclonal
anti-phospho-SMAD1/5/8 antibodies (Millipore, Billerica, MA).
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Microarray and RT-PCR analysis
Total RNA was isolated from neonatal keratinocytes and fibroblasts
using Trizol Reagent (Invitrogen). All experiments were performed
using at least three to four replicates, and RNA isolated from three to
four experimental and control samples was pooled and processed for
microarray analyses using one sample of pooled RNA per experi-
mental and control group. All microarray analyses were performed
at the Microarray Core Facility at the Boston University School of
Medicine using the Human Genome U133 2.0 array (manufactured
by Affymetrix), and the resulting data have been deposited in
NCBI’s Gene Expression Omnibus (Edgar et al., 2002) and are
accessible through GEO Series accession number GSE16111
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE16111).
After statistical analysis and initial filtering of the microarray data,
changes in gene expression after BMP-4 treatment equal to or higher
than 1.8-fold with at least one signal equal to or higher than 80
fluorescence units for the gene were considered significant. For semi-
quantitative and quantitative RT-PCR analysis, equal amounts of total
RNAwere used as a template for cDNA synthesis using the SuperScript
III First-Strand Synthesis System and random primers (Invitrogen). PCR
primers were designed using the Beacon Designer software (Premier
Biosoft International, Palo Alto, CA) and are listed in Supplementary
Table 4. Real-time PCR was performed using iCycler Thermal Cycler
(Bio-Rad, Hercules, CA). Differences between samples and controls
were calculated using the Gene Expression Macro program (Bio-Rad)
based on the DDCt equitation method.
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